Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005668-21Phase 3Completed
Phase 3, randomised, double-blind trial of ibuprofen and acetaminophen in knee arthralgia (4 arms), sponsored by Reckitt. Primary endpoints: Incidence of moderate and severe adverse events and Clinically significant laboratory or vital sign changes recorded as adverse events. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005668-21.